D. E. Shaw & Co., Inc. Cyma Bay Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $2.03 Million - $3.94 Million	-161,112 Reduced 20.19%	636,897 $15 Million
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $1.15 Million - $1.86 Million	105,608 Added 15.25%	798,009 $11.9 Million
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $1.07 Million - $1.57 Million	143,357 Added 26.11%	692,401 $7.58 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $1.65 Million - $2.69 Million	280,849 Added 104.72%	549,044 $4.79 Million
Q4 2022 Feb 14, 2023	BUY	$3.22 - $6.27 $140,334 - $273,259	43,582 Added 19.4%	268,195 $1.68 Million
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $112,816 - $173,094	-40,728 Reduced 15.35%	224,613 $786,000
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $77,298 - $152,349	-44,941 Reduced 14.48%	265,341 $782,000
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $175,878 - $231,118	63,494 Added 25.73%	310,282 $965,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $329,169 - $468,785	-101,910 Reduced 29.23%	246,788 $835,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $860,660 - $1.1 Million	-248,029 Reduced 41.56%	348,698 $1.27 Million
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $1.42 Million - $1.77 Million	-359,794 Reduced 37.61%	596,727 $2.6 Million
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $1.29 Million - $1.99 Million	-304,228 Reduced 24.13%	956,521 $4.34 Million
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $2.43 Million - $3.83 Million	-423,737 Reduced 25.16%	1,260,749 $7.24 Million
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $5.65 Million - $12.3 Million	-1,700,686 Reduced 50.24%	1,684,486 $12.2 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $1.36 Million - $4.1 Million	965,288 Added 39.89%	3,385,172 $11.8 Million
Q1 2020 May 15, 2020	BUY	$1.25 - $2.02 $497,915 - $804,630	398,332 Added 19.7%	2,419,884 $3.58 Million
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $1.77 Million - $7.88 Million	1,329,633 Added 192.17%	2,021,552 $3.96 Million
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $2.34 Million - $3.3 Million	457,244 Added 194.84%	691,919 $3.54 Million
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $1.35 Million - $3.04 Million	222,471 Added 1822.94%	234,675 $1.68 Million
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $14,182 - $23,323	1,738 Added 16.61%	12,204 $162,000
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $68,447 - $122,870	10,466 New	10,466 $82,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account